Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by ohwhatanight on Mar 26, 2016 5:56pm

Cash on hand

Don't forget  $155m was as of December 31st  .. they are generating  $25 my each month clear.   They should have $230m by now.  They could pay off off both bridge loans of $133m costing 9.5%

Throwing an extra $13m onto bottom line.  Distancing ourselves from VRX
Comment by COGT on Mar 26, 2016 8:26pm
They quietly telegraphed that if you can read between the lines .That will be the next news event IMHO Regardless there are a number of USA pharma looking for more off shore exposure to off set the threat of Clinton et al CXR will get taken out before long and the debt is a non issue with the giants in pharma IMHO 
Comment by Roller007 on Mar 26, 2016 9:19pm
Cogt:  agree that a take out is near.  Not now though as their share price is too low. I stated last week that once it's trading in the 50 Canadian range then a forty percent premium is justified by the buyer and takes it to 70-75 CAN. Cxr is fighting an uphill losing battle in the present environment as their growth by acquisition model is no longer applauded nor rewarded by the ...more  
Comment by Lumberfeverlong on Mar 26, 2016 11:18pm
Roller007, if if I were CEO of potential suitor, I would launch a bid when the share price is most depressed. The issue any suitor has at these levels is that there likely would be one or more competing bids. This company is so undervalued that it would attract financial players in addition to competing Pharma. At the end of the day we, as shareholders, will decide if the company is sold at ...more  
Comment by Roller007 on Mar 26, 2016 11:29pm
Lumberforeverlong:  buyers cannot offer over 120% premium on the present share price of the company they are buying as it will be hard to justify to their shareholders. 40-50% premium is the norm in a takeover and thus my theory of the buyout happening when Cxr hits the 50 CAN level.  On the other hand they cannot wait too lob since more of the debt will be paid every month that goes by ...more  
Comment by COGT on Mar 26, 2016 11:58pm
Lattice grit your teeth and short because #'s are out for ALL to see .....In the short term big guys will do the dd in "we can plug this ...plug that ...."but this is not a bleeding machine eyes have been here keenly awaiting post acquisition Debt being paid and low share price puts Cxr in line for a big thank you from suitor TBA
Comment by Lattice on Mar 27, 2016 12:46am
This post has been removed in accordance with Community Policy
Comment by Pj1958 on Mar 27, 2016 1:51am
Lettuce.... The only one with a disease is you, and you might need some of the psychotic meds that CXR is selling... It will add to our bottom line.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities